immunotherapy development

Global pharmaceutical and biopharmaceutical open access capability platform, WuXi AppTec, has published a report on immunotherapy, identifying that smaller biotech firms and early-stage companies will be the biggest driver behind therapy innovation. Read more


A potential new therapy for type I diabetes patients has been found to be safe and does not accelerate decline in β cell function — important in the production of insulin — in a recently published clinical trial. Read more


Sanofi is to partially fund the Human Vaccines Project, a non-profit partnership aiming to solve the primary problems impeding vaccine/immunotherapy development Read more